Pharma Journalist - Page 41 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

BenchSci and Thermo Fisher Team Up to Boost AI-Driven Research Tools

AstraZeneca and Daiichi Sankyo’s Enhertu Shows Strong Phase III Results in HER2-Positive Early Breast Cancer

Genmab to Acquire Merus in $8 Billion Deal to Bolster Cancer Pipeline

China Approves LEQEMBI IV Maintenance Dosing for Early Alzheimer’s

FDA Approves TREMFYA for Pediatric Psoriasis and Psoriatic Arthritis

Dyne Therapeutics’ DYNE-251 Gains Orphan Drug Status in Japan for Duchenne Muscular Dystrophy

Amgen to Invest $650 Million in U.S. Manufacturing Expansion, Creating Nearly 750 Jobs

FDA Approves Evkeeza for Youngest Children with Rare Genetic Cholesterol Disorder

Er-Kim and Sentynl Therapeutics Partner to Expand Access to Rare Disease Treatments in EMEA and Eurasian Markets

Biostar Pharma’s Utidelone Receives Third Orphan Drug Designation from FDA for Pancreatic Cancer